Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 32Terminated 15Withdrawn 2Unknown 2Active not recruiting 2Not yet recruiting 1

Sponsor Class

OTHER 1FED 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 1Genitourinary 1

Conditions

Prostatic Neoplasms 1Leukemia, Myeloid, Chronic-Phase 1

Interventions

Cisplatin 509Cyclophosphamide 360Carboplatin 352Radiotherapy 350Capecitabine 329Paclitaxel 325Oxaliplatin 324Gemcitabine 319Docetaxel 311Fluorouracil 283Drug Therapy 243apatinib 242Bevacizumab 229camrelizumab 214Etoposide 200Irinotecan 176Doxorubicin 175Leucovorin 161Dexamethasone 160sintilimab 142pembrolizumab 138anlotinib 136Pemetrexed 136Cytarabine 136toripalimab 129Neoadjuvant Therapy 122S 1 (combination) 120Vincristine 119Rituximab 117Radiosurgery 117

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Interventional × Ketoconazole × Clear all
NCT05638763 2022-12-06

Cytochrome P450 Inhibition to Decrease Dosage of Dasatinib for Chronic Myelogenous Leukemia

Hospital Universitario Dr. Jose E. Gonzalez

Phase 2 Unknown
15 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Chronic-Phase

NCT00870714 2009-03-27

IST 16167

Kansas City Veteran Affairs Medical Center

Phase NA Unknown
20 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡